TRANSLATIONAL IMPACT
Clinical issue
Brain and neural tube defects are among the most common human congenital malformations. One prominent example is the Chiari malformation (CM), a developmental defect characterized by abnormal growth of the brainstem and cerebellar herniation. CMs can be asymptomatic or can cause a wide range of clinical conditions. Malformations may, for instance, cause severe neural tube defects and hydrocephalus, in turn leading to incapacitating or lethal conditions. CMs and most other congenital brain defects have a pronounced genetic basis and a complex inheritance pattern. The genetic causes of these defects, and the molecular interplay between known environmental risk factors (for example, folic acid deficiency) and susceptibility genes are currently ill defined.
Results
In this study, the authors identify two genetic factors that cause Chiari-like malformations in mice. One of these genes, Suz12, is a member of a polycomb complex, a group of proteins that act as epigenetic regulators of gene expression. In comparison to normal, wild-type mice, which have two copies of Suz12, mice with only one copy of Suz12 have brain and neural tube defects. Some of the Suz12 heterozygotes show cerebellar herniation and an enlarged brainstem accompanied by occipital cortical alterations and spina bifida, almost perfectly resembling CM as seen in some human patients. The most impaired mice have downward displacement of the cerebellum, which causes hydrocephalus. The authors also demonstrate that Zac1 (also known as Plagl1 or Lot1), a regulator of neuronal proliferation, is part of the same molecular pathway affected by Suz12 deficiency.
Implications and future directions
Polycomb proteins are starting to be recognized as having a key role in human disease; this study demonstrates that polycomb protein complexes can play a role in nervous system malformations as well. This work strongly suggests that developmental brain abnormalities such as CMs can result from altered epigenetic regulation of genes involved in cell proliferation in the brain.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Alessandro Bailetti is awarded the DMM Outstanding Paper Prize 2019
The annual prize is awarded to the first author of the paper that is judged by the journal’s editors to be the most outstanding contribution to the journal that year. Alessandro Bailetti's winning paper presents results that indicate a possible connection between E(Pc) and the Tip60 complex, and leukemia. Find out more about Alessandro and read the winning paper.
Find DMM online
We may not be meeting you in person this year, but we’re always here to chat about DMM and The Company of Biologists. Join the conversation over on Twitter, email us or catch Scientific Editor Julija Hmeljak at these upcoming virtual meetings:
MRC Human Genetics Unit (Virtual) Symposium: Aberrant Cell State Transitions in Human Disease
23-24 September
Genomic Imprinting – from Biology to Disease
28 September – 1 October
ZDMS Virtual webinar series
Throughout September – December
Interview - Mohd. Salman
First author Mohd. Salman studies traumatic brain injury. In an interview, he takes us through his latest research in DMM, explaining the potential implications of the findings, and discussing Wistar rats as a model system and life as a early-career researcher.
Call for papers - The RAS Pathway: Diseases, Therapeutics and Beyond
DMM invites you to submit original research for a special issue focused on targeting the RAS pathway. The submission deadline is 1 March 2021. Find out more and showcase your breakthrough research in this special collection.
It’s a time of turmoil for young scientists
“My students are my priority – they are on the brink of their careers.”
Dr Jodie Rummer (ARC Centre of Excellence for Coral Reef Studies at James Cook University) talks about the importance of her role as a supervisor in supporting graduate students and post docs financially, intellectually and emotionally during this period of uncertainty.